Raoul S. Concepcion, MD, from Urology Associates, PC, discusses the new guidelines on prostate cancer screening that were issued by the American Urological Association.
Raoul S. Concepcion, MD, the Director of Clinical Research and a Urologic Surgeon at Urology Associates, PC, in Nashville, Tennessee, discusses the new guidelines on prostate cancer screening that were issued by the American Urological Association (AUA).
These guidelines are largely in response to recommendations made by the US Preventive Services Task Force (USPSTF) against PSA screening. Concepcion expects these guidelines to be controversial, since they seem to contradict the USPSTF.
The overarching theme, Concepcion believes, is a need for transparency with patients. The new guidelines are more individualized, stressing the importance of discussing options with patients. Moreover, Concepcion notes, it remains important to ensure that high-risk patients are aware of early detection programs.